Company / Operating Margin
Biofrontera Inc. Operating Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-46.1%
FY2025
5-year range
-104.6% / -46.1%
FY2021-FY2025
Trend
+30.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 5 years, ranging from -104.6% in FY2022 to -46.1% in FY2025.
Based on SEC 10-K filings.
-46.1% in FY2025 with a 3-year CAGR of +58.5%.
Improved from -64.8% to -46.1% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +58.5pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 30.7% year-over-year.
- Lowest operating margin in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -46.1% | +30.7% |
| FY2024 | -66.6% | -2.7% |
| FY2023 | -64.8% | +38.0% |
| FY2022 | -104.6% | -105.2% |
| FY2021 | -51.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026